Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-952-5 | CAS number: 26741-53-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3,9-bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
- EC Number:
- 247-952-5
- EC Name:
- 3,9-bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
- Cas Number:
- 26741-53-7
- Molecular formula:
- C33H50O6P2
- IUPAC Name:
- 3,9-bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
- Details on test material:
- - Substance type: White powder
- Physical state: solid
- Analytical purity: no data
- Purity test date: no data
- Lot/batch No.: H42265
- Expiration date of the lot/batch: no data
- Stability under test conditions: stable
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague Dawley, Inc., Frederick, MD (USA)
- Age at study initiation: approximately 6 to 8 weeks old
- Weight at study initiation: male 28.5 - 32.5 g, 20.5 - 25.7 g
- Assigned to test groups randomly: random
- Fasting period before study:
- Housing: Mice of the same sex were housed up to five per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 72 °F
- Humidity (%): 50 - 20%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 2003-07-28 To:2009-09-01
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Corn oil
- Details on exposure:
- The test arcle-vehicle mixture, the vehicle alone, or the positive control was administered by a single intrperitoneal injection at a dose volume of 20 mUkg. Intraperitoneal injection was selected to maximize delivery of the test arcle to the test system. All mice in the experimental and control groups were weighed immediately before dose administration, and the dose volume was based on individual body weight. Mice were observed afer dose adnistration for clinical signs of toxicity.
- Duration of treatment / exposure:
- 24h (all dose groups)
48h (high dose group) - Frequency of treatment:
- single
- Post exposure period:
- 24h (all dose groups)
48h (high dose group)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide was dissolved in sterile distiled water at a concentrtion of 2.5 mg/mL for use as the positive control.
Examinations
- Tissues and cell types examined:
- Bone marow cells (polychromatic eryocytes, PCEs)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Range-finder study.
DETAILS OF SLIDE PREPARATION
At the scheduled sacrifice times, five mice per sex per tratment were sacrificed by CO2 asphyxation. Imediately following sacrifce, the femurs were distaly exposed, cut just above the knee, and the bone marow was aspirated into a syringe contaig fetal bovine serum. The bone marow cells were trasferrd to a capped centrifuge tube containing approximately 1 mL fetal bovine serum. Two slides were prepard from each mouse. The slides were fixed in methanol, stained with May-Gruenwald-Giemsa and permanently mounted.
METHOD OF ANALYSIS
To contrl for bias, slides were coded using a random number table by an individual not involved with the scoring process. Using medium magnification (10 x 40), an area of acceptable quality was selected such that the cells were well spread and stained. Using oil immersion (10 x 100), 2000 polychromatic eryrocytes per animal were scored for the presence of micronuclei. The number of micronucleated nonnochromatic erythrocytes in the field of 2000 polychromatic eryrocytes was enumerated for each animaL. The proportion of polychromatic eryocytes to total erythrocytes was also recorded per 1000 erythrocytes. - Evaluation criteria:
- All conclusions were based on sound scientific judgement; however. as a guide to interpretation of the data, the test arcle was considered to induce a positive response if a dose-reponsive increase in micronucleated polychromatic erythrocytes was observed and one or more doses were statistically elevated relative to the vehicle control (p < 0.05, Kastenbaum-Bowman Tables) at any sampling time.
- Statistics:
- Kastenbaum-Bowman tables
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- piloerection was seen in male and female mice at 1000 and 2000 mg/kg bw
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
In the pilot toxicity study, two male mice each were exposed to the test article at a dose of 1, 10, 100, or 1000 mg/kg body weight while five male and five female mice were exposed to 2000 mg/kg. No mortity was observed during the course of the study and only piloerection was seen in male mice at 2000 mg/kg. In the absence of mortality in the pilot study, the high dose for the micronucleus test was set at 2000 mg/kg.
RESULTS OF DEFINITIVE STUDY
The definitive micronucleus study consisted of seven groups, each containing 5 male and 5 female ICR mice. Animals in five of these groups were treated either with the controls (negative or positive) or with the test item at a dose of 500, 1000, or 2000 mg/kg and were euthanized 24 hour after treatment. Animals in other two groups were treated either with the negative control or the test item at a dose of 2000 mg/kg and were euthanized 48 hours afer treatment. No mortality was observed in any male or female mice in the micronucleus study while piloerection was seen in male and female mice at 1000 and 2000 mg/kg. Bone marow cells (polychromatic eryocytes, PCEs), collected 24 and 48 hours after tratment, were examined microscopically for the presence of micronuclei (MPCEs/2000 PCEs/animal). No appreciable reduction in the ratio of polychromatic eryhrocytes to total eryhrocytes was
observed in the test article-treated groups relative to the vehicle control groups suggesting that the test arcle did not inhibit erythropoiesis. No significant increase in micronucleated polychromatic erythrocytes in test article-treated groups relative to the respective vehicle control groups was observed in maIe or female mice at 24 or 48 hours after dose administration (p > 0.05, Kastenbaum-Bowman Tables).
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.